Immunovant Congress Trades
NASDAQ: IMVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- Apr 4, 2025
Immunovant Congress trading summary
Members of Congress have disclosed 2 transactions in Immunovant (IMVT) stock, reported by 1 politician. No IMVT trades were reported with a transaction date in the past 12 months. The most active trader is Donald J. Trump (2).
The latest reported trade is a sale by Donald J. Trump dated Apr 4, 2025 and disclosed on Jul 1, 2026. The most common reported amount is $15,001 – $50,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading IMVT
IMVT trades by members of Congress
| Politician | Type | Amount | Traded | Filing |
|---|---|---|---|---|
 Donald J. TrumpRExecutive | Sell | $15,001 – $50,000 | Apr 4, 2025 | Filing for Donald J. Trump IMVT trade |
| Donald J. TrumpRExecutive | Buy | $15,001 – $50,000 | Mar 5, 2025 | Filing for Donald J. Trump IMVT trade |
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell IMVT. How Congress trading data works